跳至主要内容
临床试验/NCT03654651
NCT03654651已完成2 期

The Role of the Microbiome in Blood Glucose Regulation in Response to Peanut Consumption

Penn State University1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2018年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
51
试验地点
1
主要终点
Fasting Plasma Glucose

研究概览

简要总结

A two-period randomized crossover study will be conducted to determine the effect of peanuts on glycemic control, and elucidate the role of the microbiome in glucose regulation, in individuals with impaired fasting glucose.

详细描述

A two-period randomized crossover trial will be conducted. Participants will be randomized to receive each treatment for 6 weeks followed by a minimum 4-week wash-out period. During the peanut treatment, participants will consume one ounce per day (28 g) of peanuts as an evening snack. The control treatments will be an isocaloric higher carbohydrate snack consumed after the evening meal. Markers of glycemic control, cardiovascular risk factors and gut health will be assessed at the beginning and the end of each treatment period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Non-smoking
  • Impaired fasting glucose at screening (≥ 100 mg/dL).
  • BMI ≥20 and ≤40 kg/m2.

排除标准

  • Diagnosed diabetes or fasting glucose >126 mg/dl
  • Systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg)
  • Prescribed anti-hypertensive, lipid lowering or glucose lowering drugs
  • Established cardiovascular disease, stroke, diabetes, liver, kidney or autoimmune disease or inflammatory conditions
  • Use of supplements (psyllium, fish oil, soy lecithin, phytoestrogens) and botanicals and not willing to cease for the duration of the study
  • Pregnancy or lactation
  • Weight loss of >=10% of body weight within the 6 months prior to enrolling in the study
  • Smoking or use of any tobacco products
  • Allergy to test foods
  • Consumption of >14 alcoholic drinks/week

研究组 & 干预措施

Evening Peanut Consumption

Experimental

Participants will consume one ounce per day (28 g) of peanuts as an evening snack (i.e., after dinner and before sleep).

干预措施: Peanut (Drug)

Evening Snack

Active Comparator

Participants will consume an isocaloric higher carbohydrate snack as an evening snack (i.e., after dinner and before sleep).

干预措施: High carbohydrate snack (Drug)

结局指标

主要结局

Fasting Plasma Glucose

时间窗: 6 weeks

Within-condition mean differences (change from baseline).

次要结局

  • Fructosamine(6 weeks)
  • Central Systolic and Diastolic Blood Pressure(6 weeks)
  • Triglycerides(6 weeks)
  • Fasting Insulin(6 weeks)
  • Augmentation Index (%)(6 weeks)
  • Microbiota Alpha-diversity(6 weeks)
  • Peripheral Systolic and Diastolic Blood Pressure(6 weeks)
  • Carotid Femoral Pulse Wave Velocity(6 weeks)
  • LDL Cholesterol(6 weeks)
  • Total Cholesterol(6 weeks)
  • Body Weight(6 weeks)
  • HDL Cholesterol(6 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验